Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trevor J Kilpatrick

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 10, 2006
Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelinationBen Emery, Holly S Cate, Mark Marriott, et al.
Human Genetics|March 12, 2004
Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosisJustin P Rubio, Melanie Bahlo, Niall Tubridy, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 12, 2013
Vitamin D status: multifactorial contribution of environment, genes and other factors in healthy Australian adults across a latitude gradientRobyn M Lucas, Anne-Louise Ponsonby, Keith Dear, et al.
Metallomics : Integrated Biometal Science|January 5, 2024
Evidence for decreased copper associated with demyelination in the corpus callosum of cuprizone-treated miceJames B W Hilton, Kai Kysenius, Jeffrey R Liddell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
A phase I study of recombinant human leukemia inhibitory factor in patients with advanced cancerDishan H Gunawardana, Russell L Basser, Ian D Davis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 20, 2010
Latitudinal variation in incidence and type of first central nervous system demyelinating eventsBruce V Taylor, Robyn M Lucas, Keith Dear, et al.
Eneuro|July 7, 2017
A Brain-Derived Neurotrophic Factor-Based p75<sup>NTR</sup> Peptide Mimetic Ameliorates Experimental Autoimmune Neuritis Induced Axonal Pathology and DemyelinationDavid G Gonsalvez, Giang Tran, Jessica L Fletcher, et al.
Multiple Sclerosis and Related Disorders|September 21, 2020
Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in AustraliaNabil Seery, Vivien Li, Ai-Lan Nguyen, et al.
Human Genetics|January 13, 2006
On the utility of data from the International HapMap Project for Australian association studiesJim Stankovich, Charles J Cox, Rachel B Tan, et al.
Brain Communications|July 5, 2021
Axonal loss in major sensorimotor tracts is associated with impaired motor performance in minimally disabled multiple sclerosis patientsMyrte Strik, L Eduardo Cofré Lizama, Camille J Shanahan, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|May 10, 2006
Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelinationBen Emery, Holly S Cate, Mark Marriott, et al.
Human Genetics|March 12, 2004
Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosisJustin P Rubio, Melanie Bahlo, Niall Tubridy, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 12, 2013
Vitamin D status: multifactorial contribution of environment, genes and other factors in healthy Australian adults across a latitude gradientRobyn M Lucas, Anne-Louise Ponsonby, Keith Dear, et al.
Metallomics : Integrated Biometal Science|January 5, 2024
Evidence for decreased copper associated with demyelination in the corpus callosum of cuprizone-treated miceJames B W Hilton, Kai Kysenius, Jeffrey R Liddell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
A phase I study of recombinant human leukemia inhibitory factor in patients with advanced cancerDishan H Gunawardana, Russell L Basser, Ian D Davis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 20, 2010
Latitudinal variation in incidence and type of first central nervous system demyelinating eventsBruce V Taylor, Robyn M Lucas, Keith Dear, et al.
Eneuro|July 7, 2017
A Brain-Derived Neurotrophic Factor-Based p75<sup>NTR</sup> Peptide Mimetic Ameliorates Experimental Autoimmune Neuritis Induced Axonal Pathology and DemyelinationDavid G Gonsalvez, Giang Tran, Jessica L Fletcher, et al.
Multiple Sclerosis and Related Disorders|September 21, 2020
Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in AustraliaNabil Seery, Vivien Li, Ai-Lan Nguyen, et al.
Human Genetics|January 13, 2006
On the utility of data from the International HapMap Project for Australian association studiesJim Stankovich, Charles J Cox, Rachel B Tan, et al.
Brain Communications|July 5, 2021
Axonal loss in major sensorimotor tracts is associated with impaired motor performance in minimally disabled multiple sclerosis patientsMyrte Strik, L Eduardo Cofré Lizama, Camille J Shanahan, et al.
Pageof 12